David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
TCRT holding history
Alaunos Therapeutics, Inc. in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TCRT overviewAll 13F holders of TCRTFull Q4 2025 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −1,433−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q4 2023 | 21,500 | $2.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 21,500 | $2.36K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 21,500 | $10.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 21,500 | $12.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 21,500 | $15.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 21,500 | $31.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 21,500 | $30.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 21,500 | $11.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 21,500 | $23.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 21,500 | $39.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 21,500 | $57.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 21,500 | $77.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.